As major U.S. banks wrap up their fourth-quarter earnings, a clear divergence emerges. While PNC and Bank of America post strong results, Citigroup and JPMorgan Chase face headwinds. Truist Financial charts a middle course, meeting revenue expectations as the sector navigates a complex economic landscape.
Pharmaceutical giant Eli Lilly announces a major $3.5 billion manufacturing expansion for its weight-loss drugs and enters two strategic research collaborations in gene editing and immunology, signaling aggressive growth plans amid a recent stock valuation dip.
With its blockbuster Humira era in the rearview, AbbVie is betting big on its next-generation immunology drugs and a deep pipeline to drive growth and maintain its crown among Dividend Kings.
Harmony Biosciences CFO Sandip Kapadia has liquidated his entire direct stake in the company, a move that contrasts sharply with the firm's robust financial performance and bullish $1 billion revenue target for its flagship drug WAKIX by 2026. While the sales were pre-planned, the timing fuels debate on insider confidence versus corporate optimism.
Boston Scientific's latest earnings beat and raised guidance, fueled by strong demand for its electrophysiology devices, signal a strategic shift. The company is navigating tariff pressures while expanding margins, with major acquisitions poised to reshape its long-term profile.
Shares of Advantest Corp. have surged nearly 200% in the past year, riding the AI and advanced chipmaking wave. As the stock trades near record highs, investors are grappling with a critical question: has the rally run too far, too fast?
Fresenius SE & Co. KGaA (ETR:FRE) faces a challenging period as its stock declines, with a key profitability metric and a high dividend payout strategy raising questions about its near-term growth prospects.
The highest-ranking US and Israeli military officials held a closed-door meeting at the Pentagon last Friday, as regional tensions with Iran continue to escalate, according to US officials speaking on condition of anonymity.
Voters head to the polls in Costa Rica, with the ruling right-wing populist party aiming to secure a decisive mandate and a legislative supermajority to tackle record violence and political gridlock.
Tens of thousands gathered in Prague's Wenceslas Square on Sunday, voicing support for President Petr Pavel in his escalating constitutional dispute with Prime Minister Andrej Babiš's coalition government. The protest, organized by pro-democracy activists, highlights deep divisions over Ukraine policy and a controversial ministerial appointment.
Precious metals markets experienced one of their most volatile weeks on record, with silver plummeting 26% and gold dropping 9% in a dramatic reversal. The sell-off, triggered by shifting U.S. policy expectations, laid bare the market's recent dependence on speculative flows from China, raising questions about stability ahead of the Lunar New Year.
As the ASX braces for a turbulent week amid rate hike fears, investors are scouring the market for resilient opportunities. We delve into three penny stocks—spanning energy, retail, and healthcare—that combine financial stability with distinct growth narratives for the discerning investor.
The brutal 2022 murder of Katlyn Lyon Montgomery, a 28-year-old mother, sent shockwaves through her Virginia community. What initially seemed a mystery was unraveled by a relentless investigation that pieced together a stalking ex-boyfriend's digital footprint, leading to a first-degree murder conviction and a life sentence.
A Minnesota judge orders the release of Liam Conejo Ramos and his father from a Texas ICE facility, citing 'traumatizing children' in pursuit of deportation quotas. The case sparked national outrage over the treatment of asylum-seeking families.
A five-year analysis of Singapore Shipping Corporation reveals flat returns on capital, raising questions about its growth trajectory in a competitive maritime sector.
A discounted cash flow analysis suggests shares of the Malaysian poultry and seafood firm may be overvalued at current levels, raising questions for investors.
The European Central Bank convenes this week with a resurgent euro presenting a fresh dilemma, threatening to dampen inflation and undermine the export engine of the eurozone's largest economies just as recovery gains momentum.
Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.
In a quiet corner of an Istanbul mosque, Iraqi master calligrapher Ali Zaman has concluded a six-year spiritual and artistic journey: the creation of what is believed to be the world's largest handwritten Quran. The monumental work highlights the enduring legacy of Islamic calligraphy, an art form that flourished under Ottoman patronage and continues to find a vibrant center in modern Turkey.
The unraveling of the R&R Family of Companies is sending shockwaves through the freight industry, with a new lawsuit from Vantage Carrier alleging over $1.3 million in unpaid invoices. The case adds to a growing pile of legal claims and exposes the precarious financial exposure of carriers and small operators caught in the wake.
